Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can't, no account. As long as it's confirmed by someone other than Godfather Capital, I'm good. Thanks
IPF Immune™ is a liquid nutritional supplement that acts an immune modulator to benefit the immune system by fortifying it against infections. The active components in the supplement have been registered with the FDA for use in the U.S. under NDI reg. no. 1083. The product is produced and sold by the Company pursuant to U.S. Patent No. 8,309,072.
This ‘072 Patent, entitled "Irreversibly-Inactivated Pepsinogen Fragments for Modulating Immune Function", covers the use of Irreversibly Inactivated Pepsin Fragments (IPF) which has been shown in tests to perform an immune modulating function. The primary IPF ingredient is a complex platform that modulates the immune system and may be used alone or as a concomitant therapy for a variety of diseases. The IPF active substance in the product is derived from pepsin from the mucosa, and the method of its extraction and application is the subject of the licensed Patent invented by the Company's Chief Scientific Officer Harry Zhabilov. The immune modulator is made from purified, and lyophilized pepsin containing a polypeptide chain of 327 amino acid residues and one phosphoric acid residue. Using a proprietary method, a peptide chain of 36 amino acids, IPF, is isolated and made available in a ready-to-use liquid form.
Bro you have to click on their logo on their Instagram page to see their "story". That is where the countdown page is located
No picture on Instagram right now.
Yes I just looked them up on Instagram.. it is on one of their stories that was posted 4 hours ago... saw it with my own eyes 2 minutes ago
DRHUMI what are you trying to do?????
Ok, have you seen that page? It isn't Twitter or Instagram or Onelavi dot com.
Screenshots from the onelavi page that they posted on twitter...
I think they should have waited and announced the news on Monday.
It's good news because it means the company will start generating revenue and that is always a good thing. I think as far as pps wise it will run some Monday and maybe Tuesday but it won't be a huge jump. That is going to take 9 or 10 figure deals being announced
Yeah... And? Where did the images on people's twitter accounts supposedly from One Lavi LLC come from?
Ummm. But they do have a website on which to buy items on
Think people were faked out... One Lavi doesn't have a Twitter and their Instagram doesn't mention anything.
https://twitter.com/onelavillc
https://www.instagram.com/onelavillc/
Yeah the AUDIT may say tooooo much at this time.
Probably not, but I really have no idea. If there was anything besides NDA's preventing Charles from talking, I would lean towards the audit. However, the audit could also contain items that Charles doesn't want disclosed yet, so he could be intentionally holding that as well. It's really anyone's guess at this point....
Maybe the GOOD NEWS has started.
Monday is a big day because its day one of our company having a product on the market here in America. It’s only up from here.
MAGA do you think Africa is what holding up Charles from talking ?
Great news, but as it pertains to the pps, I don't think it's going to do much of anything. If I had to guess, and if they PR it on Monday, we'll likely see a 5-7M volume day with maybe a 3-5% green...
Yeah it makes you wonder 2B....... Couple that with the way PUMA has been trading/accumulating, and you can see where I'm going with this.
Late Aug til Oct 1 seemed brutal almost everyday. Just seemed like the other mm knew what STXG was doing, selling, so they basically just put up tons of ASK walls and the price got walked down daily basically.
We actually broke the loooong term downtrend from Feb during the run to almost .08, and while we have retraced now like 50% from there, it seems different watching L2. I could be wrong but I don't see the sell at all cost pressure we had from STXG. And like we have talked about it before, this is with basically ZERO interest from retail. You can probably count on one hand how many green days and 10+ mil share days we've had this year. So if we can get back just some of the vol, say we start to avg around 15 mil shares for a little bit, and the buys outweigh the sells, I think you'll see we can move up pretty significantly.
IPF is a good start and audited fins will go a long way to get people back interested and restoring trust. And then you have toxicology and our animal mab partner. So all these can happen by the 1Q, but of course anything can happen.
Tk..hmm..enormous..bid..fri...then.,reading...IPF..gonna..be..avail..@godfathe4cap
Unless it’s going to be available in well known major retail, this launch won’t do much of anything for us. No one in the general public has a damn clue who OneLavi is…
Is that big news or just so so news ?
RosettaLife said they were licensing EnzoImmune from Enzolytics. They are both the same product, however, the only current difference is distributing rights (Europe) that Enzoimmune has until whatever deal was struck expires/or extends/whatever.
Is there any difference between the old enzoimmune and IPF? I still have several bottles of Enzoimmune left that I purchased a while back, but if IPF is different/better, I’ll need to try that too….
BM thank you , I remember the EU toxic testing timeframe. IMO I thinking they have already started in Africa as soon as they got the confirmation of the second 28 day toxic testing. I think we are alot closer than they are letting on due to not having any requirements to report news ect in a time frame required by SEC. Lets all not forget we never saw test results from Montana pointing to the veterinarian portion probably being way further than we think. Remember that video that was taking down in the summer that was more like a presentation to BP it had alot of information dealing with the animal treatment side. IMO I think CC and company is letting everything play out behind the scenes, and as MP says the muzzle is on. I will take the muzzle being on as a great indicator that they can keep everything tight lipped and no leaks happening until they want it. AKA Bombshell . Another great indicator nothing from the doctor other than articles written but nothing pointing to ENZC expectations or forecast. Just my take on what is going on. Another thing as others have pointed out MMs could have driven this alot lower but basically holding in the .04 range for months is better than .00? , they have been told what they can do and where to keep it for sure something we can not control. All is IMO hopefully we start seeing the news we all want starting sometime in January. Let the day by day trading not bother you , we can't control. So just sit back and put your buy orders in, or sell orders in and check at the end of the day if executed and enjoy the holiday season.
GLTA
Ipf is going to be available starting this monday.. finally
$ENZC "Merry Christmas, ya filthy animal." 🔥 pic.twitter.com/REfxc7HD6y
— King of Prussia (@ImKingofPrussia) December 10, 2022
Some has said this is not such a big deal but i think because IPF has passed scrutiny ITV-1 should be ready to go for Africa.
Maybe Africa is what's keeping Charles hush hush.
The post I responded to originally brought it up. I mostly wanted to point out that A/S is what's locking out dilution for now, and what the preferred class conversion rates appear to be.
To the best of my recollection from PR's & OTC Company Disclosures, the testing of Enzolytics' product, ITV-1, which the African hospitals expressed interest in using if it passed some "toxicology" test, was to be completed in about two months after this Announcement. Or in a few months at the least. These African hospitals were standing by ready, willing, & waiting with great anticipation for this testing to be done in Europe.
It was also my understanding that the testing already done for this product in its initial application for EMA Approval was to be used in this new toxicology testing. And that this new toxicology testing would also be used to get the EMA Approval which it applied for under the new EMA rules, which Bulgaria was afterward under, as well as other European countries.
So by my estimation, the African hospitals should've already had approval by now to start using ITV-1 per the above-Announcement about its new toxicology testing, if it proved to have positive results.
Holy moly IPF looks to go on sale Monday at OneLavi according to Godfather on twitter.
I think you're right about that. It must have been intended for somebody else.
foxi, all this talk about converting , that is so far off , IF EVER , why even spend time talking about it . One just needs to be reading the disclosures as they come out.
--
The only , ONLY thing that is TRUE as of today is there is 3 Billion shares authorized and the rest is in the disclosures.
--
The Best thing or that would be VERY Intereting is if (by the way the only Symbol I have ever seen post something like this) if an update to this came out now that it is two years later.
https://www.otcmarkets.com/otcapi/company/financial-report/323613/content
Rockie and all
--
Ok some have very negative perceptions that is what it is . However when you look at the PR's , all come at least once per month more than most OTC Symbols and they are very detailed and specific to certain notes.
The last one was only 7 Business days ago and one can easily say , it addresses the issues and one has to take it the CEO is working with the team to move forward on all those issues.
--
Catalyst(s) Imminent and will be coming. There is NO WHERE where it says they are NOT GOING to happen, in fact the opposite.
---
Note Rockie on your question I just watch that one , to many variables , we will see
-----
While not expected on Monday of this coming week , I would not be surprised at any time for a further update.
https://www.otcmarkets.com/stock/ENZC/news
TK - I partially agree.... With PUMA, I completely agree and 100% believe that they are not only loading, but also somehow connected to ENZC (future partner, buyback, etc... something).
However, in regards to the push down, I disagree. STXG joined the party in Aug 2021, and yes, they've definitely had an impact. However, we didn't see a little spike because they stopped selling, we saw a little spike because they needed to reset the RSI. I posted the image below the other day, and you can see each time we had tiny & very short lived spike, all 3 were caused because they needed to reset the RSI before the push down could continue. This chart only shows 2022, but the same goes for the second half of 2021...
There are 2 main points here that stand out to me.
1. It only takes a few days and 1/10th of the volume to send the RSI from 20's back to 70, as it does to go from 70's to 20's. This is by design, and a perfect example of why they hit us with so many pre-market fakedowns. It allows them to drive the price significantly further down, with very little impact to RSI. Then the algos go to work to stretch it out.
2. When it comes time for them to reset the RSI, we never come close to getting back to where we originally began. Easy to see in the pic how the high of the second RSI reset is lower the 1st, and the high of the 3rd RSI reset is lower than the second. Etc...Etc...Etc...
This pattern is/has been one of the most tightly controlled/coordinated that I have ever seen. Didn't matter what kind of news was dropped, they drove it down. What partner was mentioned, they drove it down. These things are not normal... My point being that this isn't happening just for the fun of it. Somebody/Somebodies has been accumulating under the radar for a very long time. I also believe the 32.5M shares that they have yet to tell us anything about, are connected as well... Hopefully we learn whats going on sooner vs later....
I also noticed that but I think he got you confused with someone else, and responded to your post about IPF talking about the auditor......lol
2b......Yes, that is a big BID, especially right now considering we are only doing 2-3 million in vol right now. Hard to predict anything, but this is what happens before ENZC starts to move. We kind of bottom out, selling drys up at certain sp, and then you see the big BIDS start to come in. Let's see how the next couple weeks play out here. Holding the high .03's is the key for now imo.
Tk.. as..it.,shows @.039_1.7.Mil sh=$66k is big and and..very few sellers.,helping..MM's
I hear ya MAGA, and these next couple weeks are always interesting this time of year. I doubt we hear much until then, maybe last week of December but probably not until January.
The drive down in sp from late Aug to Oct was mainly driven by STXG imo, selling tons of shares daily. They stopped selling and the sp went back up to around .08, but has now slowly but surely come back down as there is no support above the 200 dma. I think you have to look at small battles here, and not revisiting the previous lows made would be a start imo. But getting past these moving avgs, especially the 200 and getting them to act as support, is not something I've really seen out of any OTC stock in the last 18 months.
But yes the NITE BID could have just been retail, but you've also had PUMA seemingly hoarding shares now for awhile down here also. Nothing will change without way more vol than we are witnessing, but hopefully some things get unveiled soon, especially the audited fins and IPF, so we can turn that page.
Yeah, I saw that too TK, although NITE is usually just retail. I know most think it's just my frustration talking when I say the following, but unfortunately it's been true for 19-20 months.
Yes, retail is definitely exhausted, but I believe the real problem is that because we have been beaten down and destroyed day in/day out for 19-20 months, retail would rather risk chasing, then risk buying more shares that will very likely be "cheaper tomorrow." We've been living with the "cheaper tomorrow" BS for roughly 20 months, so the large majority of anyone who's purchased shares over the past 20 months, are deep in the red; and with tax selling quickly approaching, they're just not gonna risk it.
I very strongly believe that we still need the worlds longest audit before we see anything tangible/significant from Charles. I really hope I'm wrong, but from the looks of everything, including daily volume/pps, I unfortunately believe that muzzle status and delayed audit status, continue throughout the remainder of 2022. More than anything, I would love to see some urgency around the buying, which would indicate to me that something is close.
Anyway, we'll see how it all plays out, but for the time being, I'm not holding my breath.
What are you talking about? Why would I have contact with the Auditor?
My posts/replies were talking about IPF...how did you take that topic and jump to the Audit and if they are missing anything? The Company filings showed no pending items were with Malone & Bologna MB...MB just didn't do their job and deliver the audit even after ample time and were fired, good riddance.
I am confident with the new Auditor as their track record to complete audits in a timely fashion seems really good.
I now only have 2 more comments left since I had to respond to this strange post.
GLTA
MAGA, interesting 1.7 Million BID by NITE at the open yesterday @ .0390. Never got down there all day and they seemed to want to also accumulate shares, but the vol is obviously extremely low. Seems like some seller exhaustion at this pt in time, but definitely not a lot buying interest/pressure whatsoever. Everyone seems to be waiting on seeing some of the potential near term catalysts we have been waiting for.
Company insiders (the Cotropias, Chandra and Harry) hold 395,180,000 Series B shares, so if those convert 1:10, ENZC could eliminate nearly 4 billion common shares of future dilution if alternative equity could be substituted.
That would still leave up to 1.35 billion shares yet to enter float, just from the instruments we currently have information about.
Independent Valuation Report Pre Clinical Studies
Investments
___________________________________________________________________________________
Press Release July 20-2021
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.
for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
https://www.creative-biolabs.com/
https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm
________________________________________
Press release July 21-2021
Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and
Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics
https://www.lonza.com/
https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar
_________________________________________
July 22 INTERVIEW
with
James Hicks, Charles Cotropia and Gurav Chandra
http://www.youtube.com/watch?v=mdljO9VLgj0
______________________________________________________________
COLLEGE STATION, TX August 25, 2021
Important Excerpt from this news progress update.
>>>>>><<<<<<
"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."
Enzolytics Inc. and Samsung Biologics Announce
Development and Manufacturing Agreement for Anti-
HIV and Anti-SARS-CoV-2
Important Excerpt from this news progress update.
>>>>>><<<<<<
"Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."_______
2000 North Central Expressway
Plano, TX 75074
972-292-9414
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |